ADA26: Dexcom’s G7 CGM helps TD2 diabetics not on insulin manage glucose levels

Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use ...
Zacks Investment Research on MSN

Dexcom reports positive CONNECT data for non-insulin diabetes

DexCom, Inc. DXCM recently announced positive results from its CONNECT randomized controlled trial, demonstrating that use of ...

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

DexCom, Inc. (NASDAQ:DXCM) announced today results from the CONNECT randomized controlled trial, demonstrating the use of ...

Clinical wins boost Dexcom growth story in type 2 diabetes

DexCom Inc. DXCM stock is trading higher on Monday after the diabetes management company reported positive results from its ...

Dexcom bolsters evidence for glucose sensors for Type 2 diabetes

New study results could lead to better insurance coverage of the devices for people who don’t take insulin, a researcher said ...

Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026

DexCom, Inc. (NASDAQ:DXCM) will present new clinical findings, product advancements and strategic business initiatives ...
Fierce Biotech

ADA: Dexcom CGM shows benefit in non-insulin diabetes patients

A Dexcom continuous glucose monitor (CGM) helped adults with type 2 diabetes not using insulin improve blood sugar control in ...
MobiHealthNews

Dexcom's Kevin Sayer talks new G7 clinical trial data

At the J.P. Morgan Healthcare Conference this week, Dexcom, maker of continuous glucose monitoring systems, made waves after CEO Kevin Sayer announced new clinical trial data from its yet to be ...